Bonewendé Mohamed Belemlilga | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Bonewendé Mohamed Belemlilga | Medicinal Chemistry | Best Researcher Award

Institut de Recherche en Sciences de la Santé (IRSS), Burkina Faso

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Bonewendé Mohamed Belemlilga earned his Ph.D. in Pharmaceutical Sciences, Pharmacology from Joseph KI-ZERBO University of Ouagadougou in 2019. His doctoral research was conducted in collaboration with the University of Paris-Saclay, strengthening his expertise in pharmacological experimentation and phytochemical studies.

🔬 Research Focus and Innovations

Dr. Belemlilga’s research is centered on the therapeutic properties of medicinal plants used to treat priority diseases, including:
✅ Digestive parasitosis
✅ Respiratory infections
✅ Malaria and dengue fever
✅ Liver diseases
✅ Cancer

His work at the Institut de Recherche en Sciences de la Santé (IRSS) involves pharmacological validation of medicinal plant products and developing antiparasitic phytomedicines.

🏥 Clinical Trials and Research Projects

He is the coordinator of a clinical trial project focused on developing an antiparasitic phytomedicine for treating digestive parasitosis in children. Additionally, he has led and contributed to several completed and ongoing research projects, including:
🔹 Study of the anthelmintic properties of Saba senegalensis extracts on Haemonchus contortus, funded by the Burkina Faso Ministry of Health (FARES/P1 2013).
🔹 Campus France scholarship project (895739H), supported by the French Embassy in Burkina Faso.

🌍 International Collaborations

Dr. Belemlilga actively collaborates with renowned institutions to enhance the pharmacological understanding of medicinal plants:
🔸 Université Paris-Saclay – Phytochemical characterization and antiparasitic testing
🔸 University Félix Houphouët-Boigny – Pharmacological activity research
🔸 Kwame Nkrumah University of Science and Technology – Medicinal plant-based drug development

Additionally, he is a member of the International Research Laboratory Environnement, Santé, Sociétés (IRL 3189 ESS), further solidifying his global scientific engagement.

📊 Impact and Scientific Contributions

Dr. Belemlilga’s research significantly contributes to scientific validation of traditional medicine and new therapeutic approaches. His work aids in bridging the gap between phytomedicine and modern pharmacology, offering potential solutions for neglected tropical diseases.

🔮 Future Contributions

His ongoing efforts focus on developing safe and effective plant-based medicines while continuing international collaborations to strengthen African research capacity in **phytomedicine and pharmacology

📖Notable Publications

Anthelmintic activity of Saba senegalensis (A. DC.) Pichon (Apocynaceae) extract against adult worms and eggs of Haemonchus contortus
Authors: MB Belemlilga, A Traoré, S Ouédraogo, A Kaboré, HH Tamboura, …
Journal: Asian Pacific Journal of Tropical Biomedicine
Year: 2016

Phytochemical analysis and ovicidal activity of Cassia sieberiana, Guiera senegalensis and Excoecaria grahamii extracts
Authors: A Traoré, S Ouédraogo, MB Belemlilga, A Kaboré, …
Journal: African Journal of Pharmacy and Pharmacology
Year: 2017

Evaluation of antioxidant, anti-inflammatory and analgesic activities of leaves of Saba senegalensis (A. DC) Pichon (Apocynaceae)
Authors: MB Belemlilga, TK Traoré, GAL Boly, N Ouédraogo, A Traoré, M Lompo, …
Journal: Cardiovascular Disorders
Year: 2019

Preclinical Evaluation of the Antihypertensive Effect of an Aqueous Extract of Anogeissus leiocarpa (DC) Guill et Perr. Bark of Trunk in L-NAME-Induced …
Authors: L Belemnaba, M Nitiéma, S Ilboudo, GG Ouédraogo, N Ouédraogo, …
Journal: Journal of Experimental Pharmacology
Year: 2021

Anti-inflammatory and analgesic activities of extracts from Balanites aegyptiaca L. Delile (Balanitaceae) root bark: Plant used against liver diseases in Burkina Faso
Authors: KT Traoré, N Ouédraogo, L Belemnaba, GAL Boly, CB Atchadé, MB Belemlilga, …
Journal: African Journal of Pharmacy and Pharmacology
Year: 2019

Qiang Qu | Analytical Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Qiang Qu | Analytical Chemistry | Best Researcher Award

Pfizer Research and Development, United States

👨‍🎓Profiles

🏛️ Early Academic Pursuits

Qiang Qu embarked on his academic journey with a strong foundation in biochemistry, earning a B.S. from Nankai University in 1995. He further honed his expertise by obtaining a Master’s degree in Genetics from the Chinese Academy of Sciences, Institute of Genetics in 1998. His academic training provided him with a solid understanding of molecular biology, protein analysis, and genetic mechanisms—knowledge that would later fuel his career in biopharmaceutical research and clinical assay development.

🏢 Professional Endeavors

With over 14 years of experience in the biopharmaceutical industry, Qiang Qu has played pivotal roles in assay development, clinical research, and regulatory strategy. His career began at Pfizer in 2010 as a Senior Scientist in BioMedicine Design-PDM, where he focused on bioanalytical assay development for pharmacokinetics (PK) and immunogenicity assessments. In 2016, he joined EMD Serono as an Associate Director and Lab Head, where he managed a team of scientists, overseeing assay development for large molecule therapeutics. By 2020, he returned to Pfizer as the Biologics & Immunogenicity Clinical Assay Lead, a role in which he continues to make significant contributions to the development and regulatory approval of biologics.

🔬 Contributions and Research Focus

Qiang Qu's research expertise spans PK, anti-drug antibody (ADA), and neutralizing antibody (NAb) assay development, particularly in clinical phases. He has led the development, validation, and transfer of bioanalytical assays using state-of-the-art technologies such as ELISA, MSD, Gyros, and Octet platforms. His contributions have been instrumental in ensuring the robustness, reliability, and regulatory compliance of assays used in drug development.

🌍 Impact and Influence

Through his leadership roles, Qiang Qu has had a direct influence on clinical assay strategies, shaping the scientific direction of bioanalytical projects. His collaborations with CROs (Contract Research Organizations) and regulatory bodies have ensured the successful transfer and validation of critical assays supporting IND/BLA/NDA submissions. He has also mentored and managed teams, fostering the next generation of scientists in assay development.

📚 Academic Citations & Industry Recognition

His work in biologics and immunogenicity assays has been widely recognized within the scientific community. His contributions have been cited in regulatory filings, scientific reports, and industry presentations, strengthening the scientific foundation for immunogenicity risk assessment and bioanalytical methodologies in pharmaceutical research.

🛠️ Technical Skills

Qiang Qu possesses extensive technical expertise in:

  • Bioanalytical assay development (PK, ADA, and NAb)
  • Method validation and assay transfer under GLP/GCLP compliance
  • Technology platforms: ELISA, MSD, Gyros, Octet, and automation tools
  • Regulatory compliance and dossier preparation for clinical and regulatory submissions
  • CRO management, troubleshooting, and scientific oversight

🎓 Teaching & Mentorship Experience

Throughout his career, Qiang Qu has played a significant role in mentoring junior scientists and contractors, guiding them through assay development and regulatory expectations. His leadership at EMD Serono and Pfizer involved training and supervising 6-8 direct reports, helping them build expertise in bioanalytical methodologies. His mentorship extends beyond the lab, as he frequently participates in scientific discussions, internal knowledge-sharing sessions, and industry conferences.

🔥 Legacy and Future Contributions

Qiang Qu's contributions to bioanalytical sciences and immunogenicity assay development have already left a lasting impact on the field of biologics drug development. His expertise in method validation, regulatory submissions, and clinical strategy continues to shape the future of biopharmaceutical research. Moving forward, he is poised to further enhance assay innovation, improve immunogenicity risk assessment, and contribute to emerging technologies in biologics. His legacy is one of scientific excellence, leadership, and mentorship, ensuring that his influence extends well beyond his immediate projects.

Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Ghanshyam Teli | Medicinal Chemistry | Best Researcher Award

School of Pharmacy, Sangam University, India

👨‍🎓Profiles

👨‍🎓 Early Academic Pursuits

Mr. Ghanshyam Teli’s academic journey began with a strong foundation in pharmacy. He earned his B. Pharmacy from Geetanjali University in 2019 with a commendable 73.7%. His academic pursuit continued with a M. Pharmacy from ISF College of Pharmacy in 2021, where he achieved an impressive 82%. Currently, he is pursuing his Ph.D. at Baba Farid University of Health Sciences, enhancing his expertise in the field. His early academic focus was on chemical synthesis and drug discovery, where he worked on several research projects related to anti-cancer agents and inhibitors of oncogenic pathways.

🧑‍🔬 Professional Endeavors

Mr. Teli has gained considerable professional experience, particularly in both academic and industrial settings. He has worked for 1.5 years as an Assistant Professor at the School of Pharmacy, Sangam University, Bhilwara, India, where he has been able to share his knowledge with students while continuing his research. His professional experience also includes 13 months at United Biotech Pvt Ltd as an Assistant R&D Chemist, where he contributed to several high-impact projects, including the synthesis of 4-Thiazolidinone derivatives and the development of Paclitaxel-HSA complex. Additionally, he spent 1 year as a Junior Research Fellow (JRF) at Acharya and B.M. Reddy College of Pharmacy in Bengaluru, further strengthening his research expertise.

🔬 Contributions and Research Focus

Mr. Teli's research contributions have primarily focused on drug design, synthesis, and evaluation, with a particular emphasis on creating compounds for anti-cancer treatment. His work on 4-thiazolidinone conjugates as potential anti-breast cancer agents is notable, along with his project on the discovery of triangular heterocyclic molecules to inhibit dual oncogenic pathways. His research aims to contribute to developing novel therapeutic strategies for cancer treatment, especially targeting HSP90 and BRAF kinases.

🌍 Impact and Influence

Mr. Teli's professional journey demonstrates his commitment to both academia and industry. His industrial experience has allowed him to engage in multi-step synthesis processes and biological evaluations, making a tangible impact on pharmaceutical development. As an educator, he strives to impart his knowledge and inspire the next generation of pharmacists, sharing insights from both his research and industry experience. His contributions aim to foster innovations in drug design and therapy, particularly in cancer treatments.

📚 Academic Cites and Recognition

While Mr. Teli’s academic work is still evolving, his research projects on drug discovery, particularly in the field of cancer, have the potential for future recognition and citations. His detailed work in the design and synthesis of bioactive compounds, particularly those related to anti-cancer and anti-breast cancer agents, is likely to gain traction and be cited by peers in the academic and research communities.

💻 Technical Skills

Mr. Teli is proficient in several technical aspects of pharmaceutical chemistry, including: Synthesis of chemical compounds and characterization through advanced spectroscopy techniques such as UV, IR, and 1H NMR. Docking studies and predicting ADMET properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity) for potential drug candidates. Handling specialized equipment such as Flash Chromatography, Column Chromatography, Rota-evaporator, Vacuum dryer, UV-Vis Spectrophotometer, and pH meter. Expertise in computational tools like ChemDraw, Autodock, Molegro Virtual Docker (MVD), Pymol, and Discovery Studio, which aid in the structure-activity relationship (SAR) analysis and molecular modeling.

👩‍🏫 Teaching Experience

As an Assistant Professor at the School of Pharmacy, Sangam University, Mr. Teli has honed his teaching skills, fostering a rich learning environment. His ability to explain complex concepts in pharmacy and drug design to students reflects his deep knowledge and communication skills. His teaching approach emphasizes practical application and encourages critical thinking. By sharing his industrial and research experiences, he connects students with real-world pharmaceutical challenges, aiming to inspire future innovations.

🌱 Legacy and Future Contributions

Mr. Teli’s ongoing research and academic efforts hold significant promise for the future of pharmacy education and drug discovery. His work on the synthesis of novel anti-cancer agents, especially those targeting key oncogenic pathways, has the potential to drive breakthroughs in cancer therapy. As he continues to pursue his Ph.D., Mr. Teli is committed to growing as a researcher and educator. He seeks to expand his knowledge, hone his technical skills, and make valuable contributions to drug development while guiding the next generation of pharmaceutical professionals.

📖Notable Publications

  • Synthetic product-based approach toward potential antileishmanial drug development
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2024
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
  • Authors: Pal, R., Teli, G., Sengupta, S., Maji, L., Purawarga Matada, G.S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
  • Authors: Teli, G., Pal, R., Maji, L., Purawarga Matada, G.S., Sengupta, S.
    Journal: Journal of Biomolecular Structure and Dynamics
    Year: 2024
  • Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
  • Authors: Pal, R., Teli, G., Matada, G.S.P., Dhiwar, P.S.
    Journal: Journal of Molecular Structure
    Year: 2023
  • The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
  • Authors: Pal, R., Teli, G., Akhtar, M.J., Matada, G.S.P.
    Journal: European Journal of Medicinal Chemistry
    Year: 2023

 

 

Khairy Mohamed Abdalla Zoheir | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Khairy Mohamed Abdalla Zoheir | Medicinal Chemistry | Best Researcher Award

National Research Centre, Egypt

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Khairy Mohamed Abdalla Zoheir began his distinguished academic journey with a focus on genetics, cytology, and histology. He earned both his Ph.D. and MD from Cairo University, Egypt, in July 2005. His early research laid the foundation for his future work in animal genetics and molecular biology. In pursuit of advanced knowledge, Dr. Zoheir received a two-year postdoctoral fellowship at the College of Science and Technology, Huazhong Agricultural University, Wuhan, China (2006–2008), where he deepened his expertise in cutting-edge genetic research.

💼 Professional Endeavors

Dr. Zoheir has built an illustrious career as a Professor of Animal Genetics at the Cell Biology Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt. His international experience includes a tenure as Assistant Professor of Pharmacology and Toxicology at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, from 2009 onward. Through these roles, he has contributed significantly to advancing the understanding of gene therapy and pharmacology, cementing his place as a leader in his field.

🧬 Contributions and Research Focus

Dr. Zoheir’s research revolves around RNA interference (RNAi), overexpression studies, epigenetics, and gene therapy for diseases such as cancer. His groundbreaking work extends to novel therapeutic approaches, including the development of an internationally patented anti-inflammatory topical gel containing myrrh extract (2016). His research findings also highlight the role of lipoic acid in modulating cytokines, thereby influencing wound healing. With 92 publications in SCI and Scopus-indexed journals, his contributions have significantly impacted the fields of molecular biology and pharmacology.

🌟 Impact and Influence

Dr. Zoheir’s work has garnered widespread recognition in both national and international scientific communities. His research funding achievements and numerous conference presentations underscore his commitment to knowledge dissemination and collaboration. He has authored 85 publications in prestigious journals, influencing emerging fields such as epigenetics and gene therapy. Additionally, his editorial appointment with Frontiers in Molecular Biosciences showcases his leadership in shaping the future of molecular biology research.

📚 Academic Cites and Publications

With a total of 92 SCI-indexed and Scopus-indexed publications, Dr. Zoheir has made a lasting impact on the scientific world. His work continues to be cited by peers worldwide, further establishing his reputation as a prolific researcher in molecular genetics, RNAi, and gene therapy.

🛠️ Technical Skills

Dr. Zoheir is adept in advanced molecular biology techniques such as RNA interference, gene overexpression, and epigenetics. His expertise also includes pharmacological studies and the development of novel therapeutic formulations, exemplified by his internationally patented myrrh-based topical gel.

🧑‍🏫 Teaching Experience

Throughout his career, Dr. Zoheir has demonstrated a passion for education. He has mentored numerous students and researchers, fostering their growth in genetics and molecular biology. His teaching roles at the National Research Centre and King Saud University have helped train the next generation of scientists and researchers.

🌍 Legacy and Future Contributions

Dr. Zoheir’s legacy is marked by his innovative research, impactful publications, and commitment to advancing molecular biology. As a pioneer in RNAi and gene therapy, he continues to inspire researchers worldwide. His future contributions are expected to further unravel the complexities of epigenetics and therapeutic interventions, leaving an indelible mark on the scientific community.

📖Notable Publications

 

Jun-Won Seo | Chemical Biology | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Jun-Won Seo | Chemical Biology | Best Researcher Award

Chosun University, South Korea

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Jun-Won Seo began his academic journey with a robust foundation in medicine, specializing in infectious diseases. His educational experiences shaped his expertise in internal medicine, providing him with the knowledge and skills to tackle complex infectious diseases. Through rigorous training and research, He developed a keen interest in emerging infections and antimicrobial therapies, which became the cornerstone of his career.

💼 Professional Endeavors

Currently He serving as an Assistant Professor in the Division of Infectious Diseases at Chosun University, He balances a multifaceted career that includes clinical practice, teaching, and cutting-edge research. He collaborates closely with esteemed organizations, such as the Korea Disease Control and Prevention Agency, contributing to significant projects like the evaluation of fosfomycin treatment for community-acquired infections caused by ESBL-producing pathogens.

🧪 Contributions and Research Focus

His research efforts primarily target zoonotic and tick-borne diseases. His dedication has resulted in the publication of 45 SCI-indexed and Scopus-indexed articles, reflecting his impact on the global academic community. He has been pivotal in advancing public health strategies and treatment methodologies for infectious diseases, often bridging the gap between research and clinical application.

🌍 Impact and Influence

His work has a far-reaching influence, especially in combating infectious diseases with evidence-based approaches. His recent accolades, such as the 'Young Investigator Award,' the 'TOP-rate Poster' at ECCMID 2022, and the 'International Investigator Award' at IDSA 2023, underscore his contributions to the field. His involvement in international conferences ensures the dissemination of his findings, fostering global collaboration.

📚 Academic Cites and Publications

His publication record includes contributions to prestigious journals like Viruses. His citations highlight the relevance and quality of his work, with peers frequently referencing his studies to advance their own research. This solidifies his reputation as a thought leader in infectious diseases.

🔧 Technical Skills

Equipped with a profound understanding of infectious disease dynamics, His skills extend beyond research. His technical expertise in clinical methodologies and innovative treatment approaches has allowed him to develop impactful solutions for complex medical challenges.

👩‍🏫 Teaching and Mentorship Experience

As an educator, Dr. Seo is deeply committed to mentoring the next generation of healthcare professionals. He employs a patient-centered approach in his teaching, emphasizing the importance of evidence-based practices. His students benefit from his extensive clinical experience and innovative research perspectives.

🏆 Legacy and Future Contributions

His legacy lies in his unyielding commitment to improving global health through research, education, and practice. He envisions expanding his focus on emerging zoonotic diseases and antibiotic resistance, driving advancements in both preventive and therapeutic strategies. His collaborations and publications ensure that his work continues to influence the field long into the future.

✨ Key Highlights

  • Completed/Ongoing Projects: 2 impactful studies on antimicrobial therapies.
  • Collaboration: Partnered with the Korea Disease Control and Prevention Agency.
  • Professional Membership: Active member of the Korean Society of Infectious Diseases.
  • Books: Authored a book (ISBN: 9791170681878).
  • Awards: Recognized internationally for research excellence.

📖Notable Publications

  • SARS-CoV-2 Antigenemia and RNAemia in Association with Disease Severity in Patients with COVID-19
    • Authors: Kim, D.-M., Lawrence Panchali, M.J., Kim, C.-M., ... Kim, D.Y., Yun, N.R.
    • Journal: Scientific Reports
    • Year: 2024
  • Risk Factors of Thromboembolic Events in Patients with Scrub Typhus
    • Authors: Ki, Y.J., Kim, S.S., Seo, J.-W., ... Kim, C., Kim, D.-M.
    • Journal: PLoS Neglected Tropical Diseases
    • Year: 2024
  • Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19
    • Authors: Kim, C.-M., Chung, J.K., Tamanna, S., ... Kim, D.-M., Cho, N.-H.
    • Journal: Microorganisms
    • Year: 2024
  • Risk Factors for Impaired Cellular or Humoral Immunity After Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals
    • Authors: Ko, J.-H., Kim, C.-M., Bang, M.-S., ... Kim, S.-H., Kim, D.-M.
    • Journal: Vaccines
    • Year: 2024
  • Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID
    • Authors: Seo, J.-W., Kim, S.E., Kim, Y., ... Choi, Y.J., Song, J.Y.
    • Journal: Infection and Chemotherapy
    • Year: 2024
  • Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis
    • Authors: Choi, Y.J., Seo, Y.B., Seo, J.-W., ... Kim, E.J., Song, J.Y.
    • Journal: Journal of Clinical Medicine
    • Year: 2023